Insulin therapy study recruits 60,000 patients
Kolkata, July 20 : Novo Nordisk, a leading healthcare company, on Tueesday announced the recruitment of the 60,000th patient in the A1chieve study – an observational study designed to investigate the effects of modern insulins in the management of type 2 diabetes.